Aim: To compare radiologist and artificial intelligence (AI) PI-RADS assessments of prostate mpMRI and their performance for clinically significant prostate cancer detection.Materials and Methods: This retrospective single-center study included 460 mpMRI
Hilal Şahin +5 more
core +1 more source
Long-Term Observed Risk of Clinically Significant Prostate Cancer After Negative mpMRI and Systematic Biopsy in Biopsy-Naïve Men: A MULTIPROS Subanalysis. [PDF]
Aloufi WD +5 more
europepmc +1 more source
Validating the biological origin of in vivo fractional intracellular volume from VERDICT-MRI in the prostate. [PDF]
Masramon M +24 more
europepmc +1 more source
PSMA PET/CT-Targeted Biopsy in Men with Negative or Equivocal Multiparametric MRI and Exploratory Dynamic Total-Body PET: The FUPERMAN Study. [PDF]
Farolfi A +15 more
europepmc +1 more source
From Detection to Surveillance: The Evolving Role of Micro-Ultrasound in Prostate Cancer. [PDF]
Ashrafi D, Klotz L.
europepmc +1 more source
International audienceBackgroundMultiparametric MRI (mpMRI) has become integral to prostate cancer (PCa) screening, improving detection and reducing unnecessary biopsies.
Rembeyo, Grégory +6 more
core +1 more source
Association of PI-RADS Score with Clinically Significant Prostate Cancer and Histopathological Upgrading in Patients Undergoing Radical Prostatectomy: A Retrospective Single-Centre Study. [PDF]
Krzepkowski HA +6 more
europepmc +1 more source
Impact of prostate mpMRI quality on diagnostic accuracy in prostate cancer: a prospective study. [PDF]
Cannoletta D +16 more
europepmc +1 more source
Identifying Candidates for Biopsy Omission in Prostate Cancer Using mpMRI and PSMA PET/CT. [PDF]
Esen B +11 more
europepmc +1 more source
Evaluation of Diagnostic Performance and Inter-Reader Agreement of Prostate Imaging After Focal Ablation (PI-FAB) on Post-Focal Therapy (FT) Magnetic Resonance Imaging (MRI). [PDF]
Hang G +12 more
europepmc +1 more source

